NUVL
Ticker
Nuvalent Inc
NUVL · Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancerNuvalent Inc (NUVL), in the Healthcare sector, has 52 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 0 purchases and 52 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 9 and filed Jul 10. The most active filer was Darlene Noci with 22 filings.
Add to watchlistFilings, ttm
52
0 buys · 52 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$145.6M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jul 9
Filed Jul 10
ADViAverage daily dollar volume
$288.8M
market data
Share price · 12M
$124 (+0.0%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $491.9M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
DNRecent filings
Henry E. PelishSALE
Chief Scientific Officer
$261K2,111 sh × $123.81
Exec Jul 9
Filed Jul 10 · 4:30 PM ET James Richard PorterSALE President and CEO $3.7M
30,000 sh × $123.72
Exec Jul 6
Filed Jul 8 · 4:30 PM ET Darlene NociSALE Chief Development Officer $2.8M
23,000 sh × $123.59
Exec Jul 1
Filed Jul 6 · 4:31 PM ET Alexandra BalcomSALE Chief Financial Officer $1.4M
11,430 sh × $123.58
Exec Jul 1
Filed Jul 6 · 4:30 PM ET Darlene NociSALE Chief Development Officer $679K
5,500 sh × $123.51
Exec Jun 29
Filed Jul 1 · 4:30 PM ET Darlene NociSALE Chief Development Officer $2.5M
20,000 sh × $122.81
Exec Jun 9
Filed Jun 11 · 5:30 PM ET James Richard PorterSALE President and CEO $2.7M
30,000 sh across 3 lots
Exec Jun 8
Filed Jun 10 · 5:30 PM ET Alexandra BalcomSALE Chief Financial Officer $900K
9,091 sh across 4 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Deborah Ann MillerSALE Chief Legal Officer $496K
4,600 sh across 3 lots
Exec May 28
Filed Jun 1 · 5:30 PM ET Darlene NociSALE Chief Development Officer $582K
5,400 sh across 4 lots
Exec May 28
Filed Jun 1 · 5:30 PM ET James Richard PorterSALE President and CEO $3.1M
30,000 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET Alexandra BalcomSALE Chief Financial Officer $1.1M
11,306 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET Darlene NociSALE Chief Development Officer $447K
4,500 sh × $99.35
Exec Apr 29
Filed May 1 · 5:30 PM ET Deborah Ann MillerSALE Chief Legal Officer $546K
5,500 sh across 2 lots
Exec Apr 30
Filed May 1 · 5:30 PM ET Henry E. PelishSALE Chief Scientific Officer $229K
2,193 sh × $104.27
Exec Apr 9
Filed Apr 13 · 5:30 PM ET James Richard PorterSALE President and CEO $3.1M
29,900 sh across 3 lots
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Alexandra BalcomSALE Chief Financial Officer $1.2M
11,430 sh across 3 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Darlene NociSALE Chief Development Officer $538K
5,500 sh across 2 lots
Exec Mar 30
Filed Apr 1 · 5:30 PM ET Deborah Ann MillerSALE Chief Legal Officer $451K
4,560 sh across 2 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET Alexandra BalcomSALE Chief Financial Officer $2.5M
25,130 sh across 4 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET Henry E. PelishSALE Chief Scientific Officer $3.3M
33,994 sh across 4 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET James Richard PorterSALE President and CEO $2.9M
29,600 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Deborah Ann MillerSALE Chief Legal Officer $546K
5,300 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET Darlene NociSALE Chief Development Officer $546K
5,300 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET Darlene NociSALE Chief Development Officer $536K
5,248 sh across 2 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET